Navigating Cancer Decisions: How Shared Decision Making Can Empower You
"A new model highlights the vital roles of patients and doctors in making collaborative choices about cancer treatment."
Facing a cancer diagnosis brings a whirlwind of emotions and critical decisions. Traditionally, the physician held the primary role in determining the best course of action. However, modern healthcare increasingly emphasizes shared decision making (SDM), where patients and doctors collaborate to choose the most suitable treatment path.
But what does shared decision-making really look like in oncology? A recent study published in the journal Patient Education and Counseling sheds light on this crucial question. Researchers interviewed 76 stakeholders, including cancer patients, oncologists, nurses, and SDM researchers, to construct a comprehensive model of SDM in cancer care.
This article translates the study’s findings into actionable insights, explaining how patients can actively participate in their treatment decisions, what roles doctors play in this process, and why this collaborative approach ultimately leads to better, more personalized care.
What the Evidence Shows
A 2026 U.S. scoping review examined how shared decision making (SDM) in cancer care is defined, implemented, measured, and evaluated. Of 1,259 articles it identified, 20 studies published between 2018 and 2024 were included. Separately, a 2022 review described SDM as especially important in oncology because screening and treatment decisions are complex, while noting that few articles had systematically examined SDM specifically among adults with cancer. AHRQ says further research is needed to clarify SDM’s effects on patient and provider experience and health outcomes, and to evaluate effective implementation methods.
A Person-Centered Model with Implementation Gaps
Shared decision making is grounded in making relevant choices known and treating a person’s views, priorities, and preferences as relevant to deciding what to do. It is promoted as a person-centered approach, particularly when decisions depend on individual preferences, but sources note that its implementation remains inconsistent, including in oncology and palliative cancer care. A 2026 article argues that a stronger theoretical foundation and formal representation of theories can improve clarity and testability and help build reliable evidence. Research on newly diagnosed patients with advanced cancer in hospital settings has also identified a need to better understand their SDM needs, barriers, and facilitators.
Unpacking Shared Decision Making: What Does It Really Mean?
Shared decision-making isn't simply about doctors informing patients of their options; it's a dynamic process built on mutual respect, open communication, and shared expertise. The study revealed that effective SDM incorporates various elements, both within and outside the consultation room.
- Oncologist’s Role:
- Determine possible treatment options based on medical evidence and patient factors.
- Clearly explain treatment options, including benefits, risks, and probabilities.
- Emphasize the importance of the patient's values and preferences.
- Actively listen to and learn about the patient's individual circumstances and concerns.
- Guide the patient through the decision-making process and provide treatment recommendations based on combined expertise.
- Patient’s Role:
- Ask questions to clarify understanding of treatment options.
- Express thoughts, feelings, and anxieties openly and honestly.
- Consider treatment options carefully, weighing the pros and cons in relation to personal values.
- Offer opinions and preferences regarding treatment choices.
- Ultimately, participate in making the treatment decision, either independently or in collaboration with the oncologist.
Recent Work on Decision Support and Participation
A 2024 systematic review set out to determine how decision-making interventions for advanced cancer treatment consultations function and whether they increase perceptions of SDM behaviors during consultations. A separate interview study on time in cancer treatment decision making describes physicians as having the most prominent role in involving patients, while patients also need to take an active role. A 2026 narrative review of nonchoice surgical decision making in cancer says this nuance is rarely emphasized in surgical training, which can leave clinicians unclear about how, when, and whether SDM applies in cancer surgery. Research on parental SDM for adenotonsillectomy and tympanostomy tube placement may inform future intervention design for surgical decision making, though it concerns a different clinical context.
Why Shared Decisions Can Be Difficult
Cancer decisions can be challenging because patients may face cognitive limitations and emotional factors that affect decision making. A 2025 review reports that cancer treatment choices are increasingly complex, while SDM remains limited and is not widely integrated into clinical practice. A 2022 study likewise notes that SDM is not routinely practiced in cancer care, despite different treatments having different implications for prognosis and quality of life. These sources point to a gap between SDM’s potential to support informed choices and its routine use.
Why Shared Decision Making Matters: The Benefits for You
The shift towards shared decision-making in oncology represents a profound change in the doctor-patient relationship. It recognizes that patients are not passive recipients of care but active participants in shaping their treatment journey.
Attend to Patient Factors
A commentary on translating shared decision making into oncology care thanks Vinod and colleagues for urging oncologists to appreciate patient factors in decision making. The supplied source excerpt does not specify which patient factors or describe particular clinical recommendations, so the supported takeaway is that patient factors warrant attention when decisions are made.
Decision Making as Cancer Progresses
When cancer progresses, clinicians may propose and discuss treatment changes with patients and their family caregivers. A 2026 study examines how decision making in these cancer progression consultations relates to shared decision making from the perspectives of healthcare professionals, patients, and caregivers. Its stated rationale is that research on these consultations has been insufficient. The available source description does not report the study’s findings.
Personalizing Cancer Care Pathways
A 2026 case study at a large Dutch teaching hospital examined how person-centered care, shared decision making, and service modularity are enacted in a colorectal cancer pathway. The study’s background notes that cancer care pathways can improve outcomes through standardization but may lack flexibility to address individual needs. It applied a composite model to examine how these approaches operated within that pathway. The source excerpt does not provide the case study’s results.
By embracing SDM, patients experience numerous benefits, including increased knowledge about their condition, a greater sense of control over their treatment, improved satisfaction with care, and enhanced adherence to treatment plans. Moreover, SDM can lead to treatment decisions that are better aligned with patients' values and preferences, resulting in improved quality of life.
If you're facing cancer treatment decisions, remember that you have the right to be an active participant. Ask questions, express your concerns, and work collaboratively with your oncologist to create a treatment plan that empowers you and aligns with your unique needs and goals. By embracing shared decision making, you can navigate your cancer journey with greater confidence and control.